References
- 1
Hellerhoff K, Petzfold V, Born P, et al.
MRCP versus ERCP in the evaluation of patients with suspected biliopancreatic disease:
can ERCPs be saved [abstract]?.
Gastrointest Endosc.
2001;
53
AB97
- 2
Hellerhoff K, Petzfold V, Born P, et al.
Which information can MRCP provide prior to interventional ERCP? A prospective comparative
study [abstract].
Gastrointest Endosc .
2001;
53
AB87
- 3
Alcaraz M J, de la Morena E J, Polo A, et al.
A comparative study of magnetic resonance cholangiography and direct cholangiography.
Rev Esp Enferm Dig.
2000;
92
427-438
- 4
Reinhold C, Taourel P, Bret P M, et al.
Choledocholithiasis: evaluation of MR cholangiography for diagnosis.
Radiology.
1998;
209
435-442
- 5
Varghese J C, Liddell R P, Farrell M A, et al.
Diagnostic accuracy of magnetic resonance cholangiopancreatography and ultrasound
compared with direct cholangiography in the detection of choledocholithiasis.
Clin Radiol.
2000;
55
25-35
- 6
Hashimoto S, Goto H, Hirooka Y, et al.
Virtual pancreatoscopy using transabdominal three-dimensional ultrasound [abstract].
Gastroenterology .
2001;
118
A764
- 7
Rabenstein T, Roggenbuck S, Frampe B.
Prevention of acute post-ERCP pancreatitis with heparin? Final results of a prospective
study in risk factors for AP [abstract].
Gastrointest Endosc.
2000;
51
AB184
- 8
Duvnjak M, Supane V, Simicevic V N, et al.
Octreotide acetate pretreatment in the prevention of post ERCP abdominal pain [abstract].
Gastroenterology.
2000;
118
A160
- 9
Sand J, Matikainen M, Nordback I.
Antibiotic prophylaxis reduces post-ERCP pancreatitis [abstract].
Gastroenterology .
2000;
118
A1062
- 10
Moreto M, Zaballa M, Ramirez K, et al.
Transdermal glyceryl trinitrate in the prevention of post-ERCP pancreatitis [abstract].
Gastrointest Endosc.
2000;
51
AB67
- 11
Andriulli A, Leandro G, Niro G, et al.
Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.
Gastrointest Endosc.
2000;
51
1-7
- 12
Testoni P A, Bagnolo F, Andriulli A, et al.
24-hour prophylaxis with octreotide in high-risk patients for post-ERCP pancreatitis:
results of a multicenter, randomized trial [abstract].
Gastrointest Endosc .
2001;
53
AB97
- 13
Prat F P, Amaris J, Ducot B, et al.
Nifedipine for post-ERCP pancreatitis prophylaxis: results of a prospective, double-blind
randomized study [abstract].
Gastrointest Endosc .
2001;
53
AB105
- 14
Johnston S D, McKenna A, Tham T C.
Silent myocardial ischaemia during endoscopic retrograde cholangiopancreatography
(ERCP) [abstract].
Gastrointest Endosc .
2001;
53
AB99
- 15
Christensen M, Rasmussen V, Schulze S, et al.
Vagal withdrawal during endoscopic retrograde cholangiopancreatography.
Scand J Gastroenterol.
2000;
35
96-101
- 16
Rosenberg J, Overgaard H, Anderson M M, et al.
Metoprolol prevents myocardial ischemia during endoscopic retrograde cholangiopancreatography.
Ugeskr Laeger.
1997;
159
5514-5518
- 17
Rosenberg J, Overgaard H, Andersen M, et al.
Double blind randomised controlled trial of effect of metoprolol on myocardial ischaemia
during endoscopic cholangiopancreatography.
Br Med J.
1996;
313
258-261
- 18
Rosenberg J, Jorgensen L N, Rasmussen V, et al.
Hypoxaemia and myocardial ischaemia during and after endoscopic cholangiopancreatography:
call for further studies.
Scand J Gastroenterol.
1992;
27
717-720
- 19
Tung B Y, Kimmey M B.
Biliary complications of orthotopic liver transplantation.
Dig Dis.
1999;
17
133-144
- 20
Hintze R E, Adler A, Veltzke W, et al.
Endoscopic management of biliary complications after orthotopic liver transplantation.
Hepatogastroenterology.
1997;
44
258-262
- 21
Theilmann L, Kuppers B, Kadmon M, et al.
Biliary tract strictures after orthotopic liver transplantation: diagnosis and management.
Endoscopy.
1994;
26
517-522
- 22
Pfau P R, Kochman M L, Lewis J D, et al.
Endoscopic management of postoperative biliary complications in orthotopic liver transplantation.
Gastrointest Endosc.
2000;
52
55-63
- 23
Sossenheimer M, Slivka A, Carr-Locke D.
Management of extrahepatic biliary disease after orthotopic liver transplantation:
review of the literature and results of a multicenter survey.
Endoscopy.
1996;
28
565-571
- 24
Schwartz D A, Petersen B T, Poterucha J J, et al.
Endoscopic therapy of anastomotic bile duct strictures occurring after liver transplantation.
Gastrointest Endosc.
2000;
51
169-174
- 25
Raijman I, Fukami N, Lappin J, et al.
The use of multiple stents (MS) in the management of liver transplantation-related
biliary stricture (LTBS): long-term follow-up [abstract].
Gastrointest Endosc .
2001;
53
AB106
- 26
Minami A, Nakatsu T, Uchida N, et al.
Papillary dilation vs. sphincterotomy in endoscopic removal of bile duct stones: a
randomized trial with manometric function.
Dig Dis Sci.
1995;
40
2550-2554
- 27
Staritz M, Ewe K, Meyer zum Büschenfelde K H.
Endoscopic papillary dilation (EPD) for the treatment of common bile duct stones and
papillary stenosis.
Endoscopy.
1983;
15 (Suppl 1)
197-198
- 28
Staritz M, Ewe K, Meyer zum Büschenfelde K H.
Endoscopic papillary dilatation: an alternative to papillotomy?.
Dtsch Med Wochenschr.
1982;
107
895-897
- 29
DiSario J A, Freeman M L, Bjorkman D J, et al.
Endoscopic balloon dilatation vs. sphincterotomy (EDES) for bile duct stone removal
[abstract].
Digestion .
1998;
59
26
- 30
Fujita N, Maguchi H, Komatsu Y.
Endoscopic sphincterotomy (EST) and endoscopic papillary balloon dilatation (EPBD)
for bile duct stones: preliminary report on a randomized controlled multicenter trial
[abstract].
Gastrointest Endosc .
2001;
53
AB60
- 31
Matsumoto H, Araki M, Kawanishi N, et al.
Shortened duration of balloon dilatation may reduce the incidence of pancreatitis
and the elevation of serum amylase after endoscopic papillary balloon dilatation for
extracting bile duct stones [abstract].
Gastrointest Endosc.
2001;
53
AB100
- 32
Mutignani M, Foschia F, Pandolfi M, et al.
Transnasal extraction (TNE) of residual common bile duct (CBD) stones by the Seldinger
technique [abstract].
Gastrointest Endosc.
2001;
53
AB91
- 33
Hochberger J, Bayer J, May A, et al.
Laser lithotripsy of difficult bile duct stones: results in 60 patients using a rhodamine
6G dye laser with optical stone tissue detection system.
Gut.
1998;
43
823-829
- 34
Zorcher T, Hochberger J, Schrott K M, et al.
In vitro study concerning the efficiency of the frequency-doubled double-pulse neodymium:YAG
laser (FREDDY) for lithotripsy of calculi in the urinary tract.
Lasers Surg Med.
1999;
25
38-42
- 35
Hochberger J, Maiss J, Tex S, et al.
First clinical data on laser lithotripsy of common bile duct stones with a new frequency-doubled
double-pulse Nd:YAG-laser (FREDDY) in 19 patients [abstract].
Gastrointest Endosc.
2001;
53
AB87
- 36
Saab S, Martin P, Soliman G Y, et al.
Endoscopic management of biliary leaks after T-tube removal in liver transplant recipients:
nasobiliary drainage versus biliary stenting.
Liver Transpl.
2000;
6
627-632
- 37
Mergener K, Strobel J C, Suhocki P, et al.
The role of ERCP in diagnosis and management of accessory bile duct leaks after cholecystectomy.
Gastrointest Endosc.
1999;
50
527-531
- 38
Sugiyama M, Mori T, Atomi Y.
Endoscopic nasobiliary drainage for treating bile leak after laparoscopic cholecystectomy.
Hepatogastroenterology.
1999;
46
762-765
- 39
Ryan M E, Geenen J E, Lehman G A, et al.
Endoscopic intervention for biliary leaks after laparoscopic cholecystectomy: a multicenter
review.
Gastrointest Endosc.
1998;
47
261-266
- 40
Hawes R H, Matsuda K, Trus T L, et al.
Cystic duct leak closure using poly-n-acetyl glucosamine (p-glc-nac) results in a
swine model [abstract].
Gastrointest Endosc.
2001;
53
AB99
- 41
Brodsky J A, Marks J M, Malm J A, et al.
Sphincter of Oddi injection with botulinum toxin is as effective as endobiliary stenting
in resolving cystic duct leaks in a canine model [abstract].
Gastrointest Endosc.
2001;
53
AB85
- 42
Huibregtse K, Cheng J, Coene P P, et al.
Endoscopic placement of expandable metal stents for biliary strictures: a preliminary
report on experience with 33 patients.
Endoscopy.
1989;
21
280-282
- 43
Rossi P, Bezzi M, Salvatori F M, et al.
Clinical experience with covered Wallstents for biliary malignancies: 23-month follow-up.
Cardiovasc Intervent Radiol.
1997;
20
441-447
- 44
Rossi P, Bezzi M, Rossi M, et al.
Metallic stents in malignant biliary obstruction: results of a multicenter European
study of 240 patients.
J Vasc Interv Radiol.
1994;
5
279-285
- 45
Huibregtse K, Carr-Locke D L, Cremer M, et al.
Biliary stent occlusion: a problem solved with self-expanding metal stents? European
Wallstent Study Group.
Endoscopy.
1992;
24
391-394
- 46
Howell D A, Shah R J, Desilets D J, et al.
Multicenter randomized comparative trial of the new spiral Z-stent compared to Wallstent:
final results of the ZOOM study [abstract].
Gastrointest Endosc.
2001;
53
AB60
- 47
Cunningham J T, Uflacker R, Rossi P, et al.
Multi-center clinical experience with percutaneous transhepatic deployment (PTD) and
endoscopic retrograde deployment (ERD) of an EPTFE-lined nitinol biliary self-expanding
metal stent (SEMS) [abstract].
Gastrointest Endosc.
2001;
53
AB105
- 48
Isayama H, Komatsu Y, Tsujino T, et al.
A prospective randomized study of “covered” vs. “uncovered” Diamond stent for malignant
biliary obstruction [abstract].
Gastrointest Endosc.
2001;
53
AB106
- 49
Kawase Y, Hori J, Okuno T, et al.
Clinical evaluation of covered metallic stents vs. bare stents for malignant biliary
strictures: results of a multicenter study in Japan [abstract].
Gastrointest Endosc .
2001;
53
AB99
- 50
Yoo B M, Kim J H, Park J J, et al.
Long-term follow up of covered metal stents versus uncovered metal stents for malignant
extrahepatic bile duct obstruction [abstract].
Gastrointest Endosc.
2001;
53
AB91
- 51
Pahernik S A, Dellian M, Berr F, et al.
Distribution and pharmacokinetics of Photofrin in human bile duct cancer.
J Photochem Photobiol B.
1998;
47
58-62
- 52
Zopf T, Riemann J F.
Therapy of pancreatic and bile duct tumors: value of radiotherapy and photodynamic
therapy.
Schweiz Rundsch Med Prax.
2000;
89
1293-1298
- 53
Zopf T, Riemann J F.
The change in laser usage in gastroenterology: status in 1997.
Z Gastroenterol.
1997;
35
987-997
- 54
Zoepf T, Rosenbaum A, Schneider A J, et al.
Conversion from percutaneous to transpapillary drainage in non-resectable bile duct
cancer is possible after photodynamic therapy (PDT) [abstract].
Gastrointest Endosc.
2001;
53
AB101
- 55
Ortner M AE, Berr F, Liebetruth J, et al.
Photodynamic therapy of non-resectable cholangiocarcinoma: a randomized prospective
study-first results [abstract].
Gastrointest Endosc .
2001;
53
AB85
- 56
Catalano M F, Rosenblatt M L, Geenen J E, et al.
Diagnosis of sphincter of Oddi dysfunction: comparison of sphincter of Oddi manometry,
fatty meal sonography and hepatobiliary scintigraphy [abstract].
Gastrointest Endosc.
2001;
53
AB71
- 57
Catalano M F, Rosenblatt M L, Geenen J E, et al.
Treatment of sphincter of Oddi dysfunction by endoscopic sphincterotomy: clinical
response predicted by hepatobiliary scintigraphy and fatty meal sonography [abstract].
Gastrointest Endosc.
2001;
53
AB71
- 58
Silverman W B, Johlin F C, Crowe G.
Does secretin-stimulated ultrasound (SSU) predict results of sphincter of Oddi manometry
(SOM), basal sphincter pressure (BSP) in patients suspected of having sphincter of
Oddi dysfunction (SOD)? [abstract].
Gastrointest Endosc.
2001;
53
AB100
- 59
Fogel E L, Sherman S, Bucksot T L, et al.
Sphincter of Oddi manometry (SOM): effects of droperidol in the biliary and pancreatic
sphincter [abstract].
Gastrointest Endosc.
2001;
53
AB89
- 60
Wilcox C M, Linder J, Price J, et al.
Prospective evaluation of droperidol on sphincter of Oddi manometry [abstract].
Gastrointest Endosc.
2001;
53
AB82
- 61
Bak A W, Perini R F, Muscara M, et al.
An endoscopic animal model of sphincter of Oddi dysfunction [abstract].
Gastroenterology.
2001;
120 (Suppl 1)
A390
- 62
Linder J D, Klapow J C, Geels W, et al.
Long-term follow-up of patients undergoing sphincter of Oddi manometry (SOM) and sphincterotomy
(S): evidence for a chronic pain syndrome [abstract].
Gastrointest Endosc.
2001;
53
AB87
- 63
Catalano M F, Rosenblatt M L, Geenen J E, Hogan W J.
Effectiveness in endotherapy in the treatment of chronic pancreatitis associated with
SOD [abstract].
Gastrointest Endosc.
2001;
53
AB139
- 64
Saurin J C, Chavaillon A, Napoleon B, et al.
Long-term outcome of patients after endoscopic treatment of duodenal benign ampullomas
[abstract].
Gastrointest Endosc.
2001;
53
AB64
- 65
Catalano M F, Rosenblatt M L, Geenen J E, Hogan W J.
Pancreatic endotherapy of pancreas divisum (PDV): response based on clinical presentation
and results of secretin-stimulated endoscopic ultrasound (S-EUS) [abstract].
Gastrointest Endosc.
2001;
53
AB133
- 66
Fogel E L, Kwon E, Sherman S, et al.
Pancreatic ductal alterations following small diameter, long length, unflanged pancreatic
duct (PD) stent placement [abstract].
Gastrointest Endosc.
2001;
53
AB86
- 67
Rosenblatt M L, Catalano M F, Nawra A T, et al.
The management of pancreatic duct (PD) stenting for obstructive-type pain of pancreatic
cancer [abstract].
Gastrointest Endosc.
2001;
53
AB136
- 68
Altorfer J, Muller A P, Ammann R, Munch R.
Endoscopic therapy of chronic pancreatitis (CP): long-term follow-up [abstract].
Gastrointest Endosc.
2001;
53
AB138
- 69
Kozarek R A, Brandabur J J, Gibbons R P, et al.
ERCP and ESWL for refractory pancreatic duct stones: do we really improve pain, preclude
the need for surgery? [abstract].
Gastrointest Endosc.
2001;
53
AB60
- 70
Borel I, Saurin J C, Bory R, et al.
Treatment of chronic pancreatitis using “definitive” stenting of the main pancreatic
duct [abstract].
Gastrointest Endosc.
2001;
53
AB139
- 71
Schmitt T, Wehrmann T, Caspary W F, et al.
New endoscopic method for debridement of infected peripancreatic necrosis [abstract].
Gastrointest Endosc.
2001;
53
AB131
P . Connor, M.B.Ch. B., M.R.C.P.I.
Digestive Disease Center
Medical University of South Carolina
171 Ashley Avenue
Charleston, SC 29425
USA
Fax: + 1-843-792-4184
Email: pconnor@doctor.com
